The unique and exclusive DAWES REDMAN® algorithm, validated against a library of over 100,000 pregnancies, reliably and effectively1 analyses CTG traces. It enables you to consistently1 interpret CTGs so you can formulate your clinical assessment early and confidently.
Unique
A substantial number of peer-reviewed publications1 have specifically featured the DAWES REDMAN® algorithm as implemented in Huntleigh monitors, making this evidenced-based analysis unique.
Objective
It objectively, automatically and in a numerical way analyses Fetal Heart Rates patterns against standardised criteria which define a normal CTG recordings.
Comprehensive
It delivers a complete analysis of all aspects of the CTG trace according to defined normality criteria therefore providing a more holistic view of fetal health.
Evidence-based
Designed and validated from Oxford University database of well over 100,000 CTG traces, it provides an aid to interpretations that are significantly more reliable than human assessments
Huntleigh Healthcare are the exclusive manufacturer allowed to commercialise (under Oxford University licencing) the original DAWES REDMAN® algorithm developed by professors Geoffrey Dawes and Chris Redman, at the University of Oxford.
The Sonicaid® Team3 fetal monitors and Sonicaid Centrale 3 CTG viewing and archiving system are the only globally distributed medical devices which enable you to run a printed and digital recording using the authentic and latest DAWES REDMAN® software.
Products manufactured by other companies will not have been validated against the University of Oxford’s unique database (where the system was and continues to be developed)